Clinical Trial

Prospective RegIstry for Oncologic Reirradiation (PRIOR-DK)

Study acronym: PRIOR
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The study aims to provide a setup for collecting radiotherapy-related toxicity data, loco-regional control, and overall survival data for all Danish cancer patients undergoing reirradiation with high dose intention or with the aim of local tumour control; with the ultimate aim of providing safe reirradiation to a larger group of patients. To build a reirradiation cohort database for future research
Trial Details
NCT Number NCT07528339
Lead Sponsor University of Aarhus
Conditions Radiotherapy Side Effect
Enrollment 500 participants
Start Date 2026-04-01
Primary Completion 2032-03-31 (estimated)
Study Completion 2037-03-31 (estimated)
Updated on ClinicalTrials.gov 2026-04-14